Shares of Joint Corp (NASDAQ:JYNT) have been given a consensus broker rating score of 1.50 (Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating and one has given a strong buy rating to the company.

Analysts have set a 1 year consensus target price of $5.50 for the company and are predicting that the company will post ($0.20) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Joint Corp an industry rank of 49 out of 265 based on the ratings given to its competitors.

Several equities research analysts have recently weighed in on JYNT shares. Feltl & Co. cut Joint Corp from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 24th. Zacks Investment Research raised Joint Corp from a “hold” rating to a “buy” rating and set a $2.25 price target for the company in a research note on Wednesday, August 17th. Finally, Maxim Group decreased their price target on Joint Corp from $8.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, July 1st.

Shares of Joint Corp (NASDAQ:JYNT) opened at 2.30 on Wednesday. Joint Corp has a 1-year low of $1.85 and a 1-year high of $7.90. The stock’s market cap is $29.28 million. The stock’s 50 day moving average is $2.40 and its 200-day moving average is $2.93.

Joint Corp (NASDAQ:JYNT) last issued its earnings results on Thursday, August 11th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.01. The firm earned $5 million during the quarter, compared to analyst estimates of $3.40 million. On average, analysts predict that Joint Corp will post ($0.97) EPS for the current fiscal year.

In other Joint Corp news, major shareholder Glenhill Advisors Llc bought 80,069 shares of the business’s stock in a transaction that occurred on Friday, July 1st. The shares were bought at an average price of $1.97 per share, for a total transaction of $157,735.93. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, CEO Peter D. Holt bought 30,000 shares of the business’s stock in a transaction that occurred on Monday, August 29th. The shares were acquired at an average price of $2.66 per share, for a total transaction of $79,800.00. Following the transaction, the chief executive officer now owns 10,000 shares in the company, valued at $26,600. The disclosure for this purchase can be found here.

Several large investors have recently made changes to their positions in the stock. Sanders Morris Harris Inc. raised its stake in shares of Joint Corp by 7.0% in the second quarter. Sanders Morris Harris Inc. now owns 2,063,581 shares of the company’s stock valued at $4,189,000 after buying an additional 134,753 shares during the last quarter. Skylands Capital LLC raised its position in shares of Joint Corp by 12.1% in the second quarter. Skylands Capital LLC now owns 380,734 shares of the company’s stock valued at $773,000 after buying an additional 40,950 shares during the last quarter. Boston Partners raised its position in shares of Joint Corp by 1.1% in the second quarter. Boston Partners now owns 108,550 shares of the company’s stock valued at $220,000 after buying an additional 1,170 shares during the last quarter. Finally, Emerald Acquisition Ltd. purchased a new position in shares of Joint Corp during the second quarter valued at about $108,000.

About Joint Corp

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

5 Day Chart for NASDAQ:JYNT

Get a free copy of the Zacks research report on Joint Corp (JYNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Joint Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.